VELZEN PHARMA PVT
GenericsVELZEN PHARMA PVT is a generic drug manufacturer focused on Cardiovascular.
VELZEN PHARMA PVT's Key Drugs
VELZEN PHARMA PVT's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
VELZEN PHARMA PVT's Recent FDA Approvals
New NDA/BLA approvals for VELZEN PHARMA PVT over the last two years — novel drugs only, excluding generics and label supplements.
VELZEN PHARMA PVT's Therapeutic Areas
VELZEN PHARMA PVT's approved drugs and pipeline span 1 therapeutic area, led by Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
VELZEN PHARMA PVT's Top Competitors
VELZEN PHARMA PVT's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
VELZEN PHARMA PVT Pipeline Snapshot
Active clinical trials for VELZEN PHARMA PVT across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1991-10-08
- Latest
- 2023-06-08
- Applications
- 5